The KD 17s, Book 1s, and Sabrina 2s were the next most popular models, which means two of the top four signature athletes (Kobe and Sabrina Ionescu) currently don't play in the NBA, and the other two ...

The Oregon Students Learn and Experience Research (OSLER) Program supports training and career development in clinical and translational research for professional and Ph.D. graduate students and ...

WEST LAFAYETTE, Ind. — The U.S. Department of Agriculture has selected Indianapolis as one of five hub locations to relocate the agency’s staff and other resources from the Washington, D.C., area. The ...

FIRST ON FOX: A bipartisan pair of lawmakers has proposed authorizing President Donald Trump to transfer B-2 stealth bombers and 30,000-pound "bunker buster" bombs to Israel if Iran is found to still ...

Abstract: As the demand for energy-efficient digital systems develops, circuits that limit power consumption and facilitate green communication are becoming increasingly crucial to design. This study ...

Complement-depleted and -non-depleted BALB/c mice were inoculated with Leishmania (Leishmania) amazonensis promastigotes into the hind footpad to study the role of the complement system in cutaneous ...

Dianthus Therapeutics, a clinical-stage biotechnology company, has appointed John C. King as Chief Commercial Officer, bringing over 25 years of experience in the biotechnology industry, particularly ...

Abstract: Data hiding is an important technology for privacy protection. The proposed information hiding method is based on neighborhood mean interpolation (NMI) and $1'\mathrm{s}$ complement.

The complement system is a crucial mediator of the innate immune response, interacting with other innate mechanisms and with factors of acquired immunity. It contributes significantly to cell ...

Binary decision diagrams (BDDs) are directed acyclic graphs used to represent functions over boolean variables. They have enjoyed widespread success in a number of domains, including hardware ...

After Altimmune (ALT) reported Q3 results and provided an update focused on its lead program pemvidutide, a GLP-1/glucagon dual receptor agonist in development for the treatment of obesity and ...